中新网8月3日电 据国家食药监局网站消息，标示为“法国ProCytech S.A.S”生产的“OUTLINE&EVOLUTION可注射合成凝胶”三个批次产品的氯化钠含量、丙烯酰胺单体残留和紫外吸收光谱等项目不符合标准要求，国家食药监局要求开展调查。

Beijing, aug. 3, according to the national food, the administration's web site news，Labeled as“France ProCytech S.A.S”production“OUTLINE&EVOLUTION can inject synthesis gel”Three batches of sodium chloride content、Acrylamide monomer residual and uv-vis spectra project does not accord with a standard to ask，The administration's national food requirement investigation。

　　近日，国家食品药品监督管理局接到广东省食品药品监督管理局的报告，反映在监督检查和抽验中发现，标示为“法国ProCytech S.A.S”生产的“OUTLINE&EVOLUTION可注射合成凝胶(注册号：国食药监械(进)字2005第3460818号(更))”三个批次产品(批号：U21196、U20190、U20187)的氯化钠含量、丙烯酰胺单体残留和紫外吸收光谱等项目不符合标准要求。

recently，The state food and drug administration of guangdong province received of the food and drug administration report，Reflect in the supervision and inspection and found in market，Labeled as“France ProCytech S.A.S”production“OUTLINE&EVOLUTION can inject synthesis gel(Registration number：Countries developto the food gave(into)Word 2005 no. 3460818(more))”Three batches(Batch number：U21196、U20190、U20187)Content of sodium chloride、Acrylamide monomer residual and uv-vis spectra project does not accord with a standard to ask。

　　国家局已责成广东、上海、海南省(市)食品药品监督管理局对辖区内相关医疗器械经营企业的涉嫌违法违规问题开展调查。

GuoGuJu already to instruct the guangdong、Shanghai、Hainan province(city)Food and drug administration to related medical equipment management within the jurisdiction of the alleged violations of enterprise for the survey。

　　另据海南省食品药品监督管理局报告，海南省局已责令上述产品的总代理东方伟确医疗设备有限公司召回全部“OUTLINE&EVOLUTION可注射合成凝胶”产品。

Another of hainan province, according to the food and drug administration report，Bureau of hainan province has ordered the products that east wei general medical equipment Co., LTD. All the recall“OUTLINE&EVOLUTION can inject synthesis gel”products。